NCT03740529 2026-01-27A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLEli Lilly and CompanyPhase 1/2 Completed803 enrolled 2 FDA
NCT07255963 2025-12-01Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCLThe First Affiliated Hospital of Soochow UniversityPhase 2 Recruiting29 enrolled